The Pasteur Museum is housed in the apartment where Louis Pasteur spent his final seven years and offers a rare behind-the-scenes look at the living and working environment of the world-renowned scientist. Visitors can gain a unique insight into his everyday life alongside his wife and can admire his rich and diverse scientific work.
The Institut Pasteur’s scientific strategy focuses on developing original and innovative topics and promoting interdisciplinary and multidisciplinary cooperation and approaches. The Institut Pasteur teams have access to the technological resources needed to speed up and further improve the quality of their outstanding research.
Ever since the introduction of the world’s first "Technical Microbiology" course in 1889, teaching has been a priority for the Institut Pasteur. The Institut Pasteur has an international reputation for quality teaching that attracts students from all over the world who come to further their training or top up their degree programs.
The mission of the Industrial Partnership team is to detect, promote, assist and protect the inventive activities from research (inventions, know-how and biological materials) conducted at the Institut Pasteur (and in some Institutes of its international network), and transfer there to industrial and/or institutional partners, in order to serve the patient needs and for the benefit of the society, as well as to contribute to sustainability of the Institut Pasteur’s resources.
With international courses, PhD and postdoctoral traineeship, each institute of the Institut Pasteur International Network (RIIP) contributes to the transmission of knowledge with the training of young researchers all around the world. In this context, doctoral and postdoctoral programmes, study and traineeship fellowships are available to scientists. Alongside training, dynamism and attractiveness of RIIP will result in the creation of 4-year group for the young researchers.
Discuss recent advances, implications, impact and perspectives of microbiota on health and diseases. Research in microbiota is facing important challenges. To date, the most relevant challenge is whether we can modulate and manipulate the human gut microbiota?
Modelling Social Contact Data: a smoothing constrained approach
Mathematical modelling of infectious diseases transmitted by the respiratory or close-contact route (e.g. influenza) is increasingly being used to determine the impact of possible interventions. Several authors have shown that informing mathematical models with social contact data is of great value avoiding making a priori contact assumptions with little or no empirical basis.
to 13.09.2014 17:30
Place : At Institut Pasteur
Scientific Symposium of the Institut Pasteur International Network
From September 10th to September 13th Institut Pasteur Paris will host the Scientific Symposium of the Institut Pasteur International Network - a three-day scientific conference - followed by the different meetings with the Directors from the Network.
How to tell if the honeymoon is over: testing hypotheses about pertussis and its resurgence
Pertussis (whooping cough) is currently resurgent in the U.S. and several other countries, despite high and sustained vaccine coverage.
In this talk, I use stochastic, nonlinear dynamical systems models as expressions of several competing hypotheses for the resurgence and confront them with long time series of epidemiological data to try and sort out the best explanation.
The Young Researchers in Life Sciences association invites you to attend the *5th annual YRLS Conference*. This conference is a venue for young scientists from various fields and different countries to present their work, exchange ideas, learn from experts and form new collaborations.
Organized by some of the leading research institutes in France, each year we welcome approximately 300 attendees from more than 10 different countries.
Technology Transfer Summit Europe, 8th year TTS Europe
TTS Europe is the only interactive round-table summit gathering high-level, early-stage biotech innovation KOLs and decision-makers from across all of the key stakeholder groups: tech transfer offices, public research, patient organizations, foundations, venture capital, corporate venture, investment banks, start-ups, SMEs, big pharma, and health related industry.